- 824: CENTRALIZING OUT-OF-HOSPITAL CARDIAC ARREST PATHWAYS FOR PATIENTS IN WALES, UK: ROOM FOR IMPROVEMENT
Critical Care Medicine · 2026
- 1425: RISK MITIGATION FOR PERCUTANEOUS CORONARY INTERVENTION IN THE CARDIAC CATHETERIZATION LAB
Critical Care Medicine · 2026
- “Roundabout” Bailout Stenting for Subacute Right Coronary Artery Obstruction After Self-Expandable Transcatheter Aortic Valve Replacement
JACC Case Reports · 2026
- Impact of Type 2 Diabetes Mellitus on In-Hospital Outcomes in Patients with ST-Elevation Myocardial Infarction: A Nationwide Study in Germany
Metabolism Open · 2026
- Evaluation of a Meds-to-Beds Program to Reduce Readmissions After Percutaneous Coronary Intervention
JACC Advances · 2026
- Association of traditional Chinese medicine syndromes with blood lipid profiles and cardiovascular prognosis in post-percutaneous coronary intervention atherosclerotic cardiovascular disease patients: a prospective cohort study
Digital Chinese Medicine · 2026
- Percutaneous Coronary Intervention in a Sitting Position During Heart Failure Following Myocardial Infarction
JACC Case Reports · 2026
- Sex-Based Outcomes in Patients With High Bleeding Risk After PCI With 1-Month DAPT: Results From the Onyx ONE Clear Trial
Journal of the Society for Cardiovascular Angiography & Interventions · 2026
- Intracoronary ECG May Reveal Dynamic Changes in Tissue-Level Reperfusion During Primary PCI
JACC Case Reports · 2026
- Intracoronary vasoactive therapy for no-reflow during primary PCI
European Heart Journal Supplements · 2026
- Ticagrelor 60 mg vs. 90 mg in elderly ACS patients with vs. without diabetes undergoing percutaneous coronary intervention
European Heart Journal Supplements · 2026
- Through the mesh - coronary access after TAVI
European Heart Journal Supplements · 2026
- Cutting-balloon fenestration of intramural haematoma in coronary dissections: single-centre experience
European Heart Journal Supplements · 2026
- Survival benefit of percutaneous coronary intervention in acute coronary syndrome: impact of left ventricular ejection fraction
European Heart Journal Supplements · 2026
- Breaking stereotypes: baseline features, treatment strategies, and 12-month outcomes in SCAD AMI patients: findings from the Serbian SCAD registry (SR SCAD)
European Heart Journal Supplements · 2026
- Potent P2Y12 inhibitors versus clopidogrel in high ischemic and low bleeding risk patients undergoing percutaneous coronary intervention for chronic coronary syndromes
European Heart Journal Supplements · 2026
- A novel sirolimus-coated balloon versus a paclitaxel-coated balloon for coronary artery disease: the SELSEQ registry
European Heart Journal Supplements · 2026
- Impact of different infusion routes in STEMI patients with high thrombotic risk
European Heart Journal Supplements · 2026
- One-month DAPT after biodegradable-polymer everolimus-eluting stent implantation in diabetic patients at high-bleeding risk: insights from the POEM trial
European Heart Journal Supplements · 2026
- State-of-the-art practice in 3VD CAD combining predictive score, contemporary CTO expertise, angiography-derived physiology, intravascular Imaging and P2Y12 mono therapy: The Multivessel TALENT
European Heart Journal Supplements · 2026
- Early oral anticoagulation monotherapy after PCI: insights from the POEM trial
European Heart Journal Supplements · 2026
- Polymer-free amphilimus-eluting stents vs. biodegradable-polymer everolimus-eluting stents in all-comers undergoing pci: 2-year results of the PARTHENOPE trial
European Heart Journal Supplements · 2026
- Cross-sectional analysis of primary PCI provision and AMI mortality across europe: accounting for economic and disease burden
European Heart Journal Supplements · 2026
- What makes it stentless? Development and internal validation of bailout risk score in DCB-only PCI
European Heart Journal Supplements · 2026
- Impact of direct oral anticoagulants on target lesion revascularization rates in patients with chronic coronary syndrome
European Heart Journal Supplements · 2026
- Current practice of european operators in the treatment of chronic total occlusions with multivessel disease: insights from multivessel TALENT
European Heart Journal Supplements · 2026
- Major bleeding complication in patients with CS on Impella and undergoing Impella assisted high risk percutaneous coronary intervention. Results of IMPELLA PL registry
European Heart Journal Supplements · 2026
- Intravascular lithotripsy for calcified left main coronary artery disease - insights from a multicenter registry
European Heart Journal Supplements · 2026
- Long-term outcomes following drug-coated balloons versus thin-strut drug-eluting stents for treatment of in-stent restenosis in acute coronary syndrome (ACS dragon-registry)
European Heart Journal Supplements · 2026
- Intravascular lithotripsy for calcified coronary lesions: insights across body mass index categories
European Heart Journal Supplements · 2026
- Current practice of European operators in the treatment of bifurcation lesions in patients with multivessel disease and data collection for the MADS-2 classification: insights from Multivessel TALENT
European Heart Journal Supplements · 2026
- Biolimus A9-eluting stents versus other limus-eluting stents in percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials
European Heart Journal Supplements · 2026
- Immediate versus staged complete revascularization in a real-world cohort of patients with ST-elevation myocardial infarction and multivessel disease
European Heart Journal Supplements · 2026
- Single-session strategy for severe aortic stenosis with coronary disease: a retrospective observational study
European Heart Journal Supplements · 2026
- Clopidogrel versus aspirin as long-term monotherapy after PCI with drug-eluting stents: a systematic review and meta-analysis
European Heart Journal Supplements · 2026
- Complete versus incomplete coronary revascularization in patients undergoing PCI after TAVI: insights from the multicenter REVIVAL-PCI registry
European Heart Journal Supplements · 2026
- Novel device success algorithm of the european association of percutaneous cardiovascular interventions (EAPCI) prospectively applied in the all-comer PIONEER IV trial
European Heart Journal Supplements · 2026
- 6 to 12-month vs. 1-month dual antiplatelet therapy: comparative outcomes after aspirin cessation with HT supreme stent in the pooled PIONEER III and PIONEER IV trial analysis
European Heart Journal Supplements · 2026
- Impact of sex on residual angina after percutaneous coronary interventions
European Heart Journal Supplements · 2026
- Percutaneous coronary intervention for left main coronary artery disease: temporal trends and in-hospital outcomes from a 12-year consecutive cohort
European Heart Journal Supplements · 2026
- Anatomical and functional concordance in assessing coronary artery disease complexity
European Heart Journal Supplements · 2026
- Differences in high-sensitivity troponin assay and association with myocardial injury and periprocedural MI after PCI for de novo three-vessel disease: insights from Multivessel TALENT
European Heart Journal Supplements · 2026
- Comprehensive multicenter evaluation of drug-coated balloon angioplasty in de novo and in-stent restenosis lesions
European Heart Journal Supplements · 2026
- Does the presence of transcatheter aortic valve replacement (TAVR) service impact acute myocardial infarction care? A binational analysis from MINAP and SWEDEHEART between 2015-2019
European Heart Journal Supplements · 2026
- Double-kissing culotte versus culotte in acute coronary syndrome: two-year results from the LSCBR registry
European Heart Journal Supplements · 2026
- Impact of P2Y12 inhibitor pretreatment on angiographic findings and clinical outcomes in patients with ST-elevation myocardial infarction
European Heart Journal Supplements · 2026
- Impact of pullback pressure gradient on clinical outcomes after percutaneous coronary interventions
European Heart Journal Supplements · 2026
- One-year outcomes of high-risk percutaneous coronary interventions with versus without mechanical circulatory support: propensity score-matched analysis
European Heart Journal Supplements · 2026
- Ischemic and bleeding events after complex versus non-complex PCI; a systematic review and meta-analysis
European Heart Journal Supplements · 2026
- Sex differences among elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention receiving ticagrelor 60 mg vs. 90 mg: a post-hoc analysis of a randomized trial
European Heart Journal Supplements · 2026